Jessica Altman, MD
Northwestern University
3
3
1
N/A
0
0
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (3)
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Mojca Jongen-Lavrencic, MD
Erasmus Medical Center
Shared therapeutic areas:
Worked with same sponsors:
David A Rizzieri, MD
Duke University
Shared therapeutic areas:
Worked with same sponsors:
Raoul Tibes, MD
Mayo Clinic Scottsdale-Phoenix
Shared therapeutic areas:
Worked with same sponsors:
Jesus Berdeja, MD
SCRI Development Innovations, LLC
Shared therapeutic areas:
Worked with same sponsors:
Hartmut Döhner, MD
Universitätsklinikum Ulm
Shared therapeutic areas:
Worked with same sponsors:
Martin S. Tallman, MD
Memorial Sloan Kettering Cancer Center
Shared therapeutic areas:
Worked with same sponsors:
Guillermo Garcia-Manero, MD
M.D. Anderson Cancer Center
Shared therapeutic areas:
Worked with same sponsors:
Jorge Cortes, MD
M.D. Anderson Cancer Center
Shared therapeutic areas:
Mary Horowitz, MD
Center for International Blood and Marrow Transplant Research
Shared therapeutic areas:
Richard W Childs, M.D.
National Heart, Lung, and Blood Institute (NHLBI)
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (3)
Showing 3 of 3 trials
Metformin+Cytarabine for the Treatment of Relapsed/Refractory AML
The Role of Maintenance Oral Clofarabine in Older Adults With Acute Myeloid Leukemia
A Phase 1, Open-Label, Dose-Escalation & Expanded Cohort, Continuous IV Infusion, Multi-center Study of the Safety, Tolerability,PK & PD of EPZ-5676 in Treatment Relapsed/Refractory Patients With Leukemias Involving
All 3 trials loaded